< Back to Article

Patients with atrial fibrillation and outcomes of cerebral infarction in those with treatment of warfarin versus no warfarin with references to CHA₂DS₂-VASc score, age and sex - A Swedish nationwide observational study with 48 433 patients

Fig 5

Risk of cerebral bleeding in men 65–74 years of age with atrial fibrillation and one point from the CHA₂DS₂-VASc score.

doi: https://doi.org/10.1371/journal.pone.0176846.g005